Invitae Corporation
LSE: 0JDB.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Kenneth D. Knight
- Employees
- 1,700
- Headquarters
- San Francisco, United States
- IPO year
- 2018
- Market cap
- $114.6K
- Website
- https://www.invitae.com
Loading 0JDB…
Loading profile data…Frequently asked questions about 0JDB
What does Invitae Corporation (0JDB.L) do?
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
Where does 0JDB.L trade?
Invitae Corporation (0JDB.L) trades on the London Stock Exchange.
What sector is 0JDB.L in?
Invitae Corporation (0JDB.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Invitae Corporation?
Kenneth D. Knight is the chief executive officer of Invitae Corporation (0JDB.L).
Where is Invitae Corporation headquartered?
Invitae Corporation is headquartered in United States.
Does 0JDB.L pay a dividend?
Invitae Corporation (0JDB.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0JDB.L go public?
Invitae Corporation (0JDB.L) completed its initial public offering in 2018.